Finance

Lists
688253:SHA
Innovita Biological Technology Co Ltd
CNÂ¥55.90
-1.58%
(-0.90) 1D
Sep 8, 3:00:03 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 688253...
Open
CNÂ¥56.61
High
CNÂ¥57.79
Low
CNÂ¥55.60
Mkt. cap
7.78B
Avg. vol.
2.29M
Volume
880.41K
Dividend
0.81%
Quarterly dividend
CNÂ¥0.11
Ex-dividend date
Jun 16, 2026
P/E ratio
151.36
52-wk high
CNÂ¥73.58
52-wk low
CNÂ¥30.00
EPS
CNÂ¥0.37
No. of employees
571
Open
CNÂ¥56.61
High
CNÂ¥57.79
Low
CNÂ¥55.60
Mkt. cap
7.78B
Avg. vol.
2.29M
Volume
880.41K
Dividend
0.81%
Quarterly dividend
CNÂ¥0.11
Ex-dividend date
Jun 16, 2026
P/E ratio
151.36
52-wk high
CNÂ¥73.58
52-wk low
CNÂ¥30.00
EPS
CNÂ¥0.37
No. of employees
571
About Innovita Biological Technology Co Ltd
CEO-
Employees571
FoundedFeb 6, 2006
Headquarters-
SectorMedical device
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
53.97M
91.63M
108.81M
31.92M
Cost of goods sold
14.59M
24.44M
25.72M
14.97M
Cost of revenue
14.59M
24.44M
25.72M
14.97M
Research and development expenses
18.80M
34.36M
18.06M
18.05M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
21.56M
27.19M
27.64M
20.88M
Operating expense
34.65M
63.66M
41.76M
44.12M
Total operating expenses
49.25M
88.11M
67.47M
59.09M
Operating income
4.72M
3.53M
41.34M
-27.17M
Other non operating income
-579.01K
417.93K
-818.17K
9.41M
EBT including unusual items
5.53M
12.61M
46.00M
-12.01M
EBT excluding unusual items
9.77M
9.10M
43.11M
-14.26M
Income tax expense
-590.12K
-680.12K
5.37M
-2.49M
Effective tax rate
-10.68%
-5.40%
11.67%
20.76%
Other operating expenses
-814.33K
1.89M
1.22M
30.06K
Net income
6.12M
13.29M
40.63M
-9.52M
Net profit margin
11.34%
14.50%
37.34%
-29.82%
Earnings per share
-
-
-
-
Interest and investment income
5.41M
6.40M
2.65M
3.49M
Interest expense
-51.23K
-50.93K
-54.50K
-
Net interest expenses
5.36M
6.35M
2.59M
3.49M
Depreciation and amortization charges
-
-
-
-
EBITDA
9.39M
9.17M
46.98M
-21.15M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google apps